The US cytomegalovirus treatment market is expanding due to the growing need for effective management of CMV infections, particularly among immunocompromised patients, transplant recipients, and individuals at higher risk of complications. Increasing awareness, improvements in diagnostic capabilities, and continued development of antiviral therapies are supporting market growth. Greater focus...